Please login to the form below

Not currently logged in
Email:
Password:

Ergomed appoints CEO of PrimeVigilance

Dr Jan Petracek to drive pharmacoviglance business

Jan_Petracek_ErgomedErgomed has appointed Dr Jan Petracek the new CEO of its pharmacoviglance business PrimeVigilance.

Dr Petracek was previously CEO of European PharmInvent Services, which Ergomed acquired in 2016 and subsequently integrated into PrimeVigilance, and prior to that he served at the likes of MediWound and Vertext Pharmaceuticals.

Dr Miroslav Reljanovic, CEO of Ergomed, said: “We are fortunate to have in the wings a replacement CEO of the calibre of Dr Jan Petracek.

“As founder of PharmInvent and former regulator at EMA, his unique combination of entrepreneurship and specialist pharmacoviglance expertise will serve to drive forward our pharmacoviglance businesses.”

Petracek will succeed Neil Clark who will become CEO of Destiny Pharma and will remain on Ergomed’s board of PrimeVigilance as a non-executive director and consultant during a transition period.

26th April 2017

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics